STAAR Surgical | STAA - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Bausch Health Companies USD 2.08B 294M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Cerus USD 33.33M 8.66M 2024-12
Cooper Companies USD 735.4M 40.2M 2026-03
J&J USD 18.55B 1.31B 2026-06
Merit Medical Systems USD 215.17M 30.37M 2026-06
Novartis USD 11.24B 1.18B 2026-06
OraSure Technologies USD 11.34M 435K 2025-12
Orthofix International USD 153.28M 4.76M 2025-12
Rockwell Medical USD 4.55M 1.49M 2024-06
STAAR Surgical USD 69.73M 868K 2026-06
Utah Medical Products USD 5.8M 450K 2024-09